Osteoporosis Anabolic Drugs Market Size, Share, and Industry Analysis, By Molecule Type (PTH Analogs, Sclerostin Inhibitors, Next-gen Anabolics, and Others), By Route of Administration (Injectable and Other Parenteral), By Patient Segment (Postmenopausal osteoporosis, Male osteoporosis, Glucocorticoid-induced osteoporosis, and High-fracture-risk / severe osteoporosis), By Distribution Channel (Hospital Pharmacies, Retail & Specialty Pharmacies, and Online), and Regional Forecast 2026-2034